Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 4
1997 1
1998 1
1999 1
2000 2
2001 1
2003 1
2004 1
2005 8
2006 3
2007 5
2008 10
2009 7
2010 9
2011 12
2012 8
2013 8
2014 9
2015 6
2016 11
2017 15
2018 11
2019 12
2020 9
2021 9
2022 15
Text availability
Article attribute
Article type
Publication date

Search Results

163 results
Results by year
Filters applied: . Clear all
Page 1
Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors.
Singh A, Venkannagari S, Oh KH, Zhang YQ, Rohde JM, Liu L, Nimmagadda S, Sudini K, Brimacombe KR, Gajghate S, Ma J, Wang A, Xu X, Shahane SA, Xia M, Woo J, Mensah GA, Wang Z, Ferrer M, Gabrielson E, Li Z, Rastinejad F, Shen M, Boxer MB, Biswal S. Singh A, et al. Among authors: nimmagadda s. ACS Chem Biol. 2016 Nov 18;11(11):3214-3225. doi: 10.1021/acschembio.6b00651. Epub 2016 Oct 17. ACS Chem Biol. 2016. PMID: 27552339 Free PMC article.
The intricate role of CXCR4 in cancer.
Chatterjee S, Behnam Azad B, Nimmagadda S. Chatterjee S, et al. Among authors: nimmagadda s. Adv Cancer Res. 2014;124:31-82. doi: 10.1016/B978-0-12-411638-2.00002-1. Adv Cancer Res. 2014. PMID: 25287686 Free PMC article. Review.
Ovarian Cancer Targeted Theranostics.
Nimmagadda S, Penet MF. Nimmagadda S, et al. Front Oncol. 2020 Jan 21;9:1537. doi: 10.3389/fonc.2019.01537. eCollection 2019. Front Oncol. 2020. PMID: 32039018 Free PMC article. Review.
CXCR4-based imaging agents.
Woodard LE, Nimmagadda S. Woodard LE, et al. Among authors: nimmagadda s. J Nucl Med. 2011 Nov;52(11):1665-9. doi: 10.2967/jnumed.111.097733. J Nucl Med. 2011. PMID: 22045705 Free PMC article. Review.
Peptide-based PET quantifies target engagement of PD-L1 therapeutics.
Kumar D, Lisok A, Dahmane E, McCoy M, Shelake S, Chatterjee S, Allaj V, Sysa-Shah P, Wharram B, Lesniak WG, Tully E, Gabrielson E, Jaffee EM, Poirier JT, Rudin CM, Gobburu JV, Pomper MG, Nimmagadda S. Kumar D, et al. Among authors: nimmagadda s. J Clin Invest. 2019 Feb 1;129(2):616-630. doi: 10.1172/JCI122216. Epub 2019 Jan 7. J Clin Invest. 2019. PMID: 30457978 Free PMC article.
Imaging virus-associated cancer.
Fu DX, Foss CA, Nimmagadda S, Ambinder RF, Pomper MG. Fu DX, et al. Among authors: nimmagadda s. Curr Pharm Des. 2008;14(28):3048-65. doi: 10.2174/138161208786404371. Curr Pharm Des. 2008. PMID: 18991718 Free PMC article. Review.
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics.
Kumar D, Mishra A, Lisok A, Kureshi R, Shelake S, Plyku D, Sen R, Doucet M, De Silva RA, Mease RC, Forde PM, Jaffee EM, Desai P, Ganguly S, Gabrielson E, Vaidya D, Spangler JB, Nimmagadda S. Kumar D, et al. Among authors: nimmagadda s. Proc Natl Acad Sci U S A. 2021 Sep 14;118(37):e2107982118. doi: 10.1073/pnas.2107982118. Proc Natl Acad Sci U S A. 2021. PMID: 34508005 Free PMC article.
Allergy: etiology and epidemiology.
Nimmagadda SR, Evans R 3rd. Nimmagadda SR, et al. Pediatr Rev. 1999 Apr;20(4):111-5; quiz 116. doi: 10.1542/pir.20-4-110. Pediatr Rev. 1999. PMID: 10208083 Review.
163 results